ResMed Inc
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Global Devices — Revenue Growth YoY by Quarter
Global Devices — Revenue Growth YoY (%) (%)
ResMed Global Devices — Revenue Growth YoY: 6.0% in Q1 FY27, down 3.0 pts from a year earlier.
Latest, Q1 FY27
6.0%
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-3.0 pts
9.0% in Q1 FY26
History
21 quarters
Since Q1 FY22
Sources
21
Documents cited below
Where the Q1 FY27 figure comes from
“Net revenue from devices for the three months ended September 30, 2026 increased to $720 million from $680 million for the three months ended September 30, 2025, an increase of $40 million or 6%, including an increase of 6% in the Americas and an increase of 6% in Rest of World (a 6% increase on a constant currency basis). Excluding the impact of foreign currency movements, device sales for the three months ended September 30, 2026 increased by 6”
Source: ResMed SEC Filing (0000943819-26-000089) ↗
Reported in ResMed Form 8-K & Form 10-Q MD&A Revenue Tables.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). ResMed Global Devices — Revenue Growth YoY (%), quarterly Q1 FY22–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-yoy
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?